A molecular mechanism of regulation for granulocyte macrophage colony stimulating factor from T lymphocytes
✍ Scribed by Marianne Frölich
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 608 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have partially purified a mitogenic factor, termed colony stimulating factor, which is secreted from a human T lymphocytic cell line, and which stimulates in vitro formation of colonies of macrophages and granulocytes by human bone marrow cells. Colony stimulating factor (CSF) produced by cells grown in serum supplemented media has a molecular weight of 60,000. It easily dissociates into a low (20,000) and a high (40,000) molecular weight component. The low molecular weight component, F I, initiates colony formation by a subset of the marrow cells. F II, the high molecular weight component, is inactive by itself, but reconstitution of F I with F II causes a dramatic increase in the number of target cells that form colonies. In serum‐free media the T‐cell line secretes only F I, which can be activated by F II. F II is only present when serum has been added to the medium, yet it is not present in the serum. Therefore, either the lymphocytes modify a component of the serum or they are stimulated to secrete F II by the serum. The molecular properties of this CSF suggest a possible mechanism of regulation of similar factors in that dissociation and reassociation may be physiologically important in determining which cell population is activated in hematopoesis.
📜 SIMILAR VOLUMES
A therapeutic trial of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was attempted in a patient with neutropenia and frequent infections secondary to T-y lymphoproliferative disease (T-y LPD). During the 14 days of subcutaneous rhGM-CSF (500 kg/m2/day), the absolute e
Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances and primes monocyte functions, but its role in monocyte migration is poorly understood. We examined monocyte migration across human umbilical vein endothelial cells (HUVEC) grown on filters. GM-CSF had no chemotactic or chemokinetic
This is a double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of granulocyte-macrophage colony-stimulating-factor (GM-CSF) after dose-intensive cyclophosphamide, etoposide, and clspiatln (DEEP). Fifty-six patients with lymphoma or breast carcinoma were randomized to